The protocol describes a study of the systemic and local skin effects of Ultraviolet B exposure in mice.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
The protocol describes a study of the systemic and local skin effects of Ultraviolet B exposure in mice.
Ultraviolet B (UVB) radiation (280-320 nm) has been recognized as a carcinogen since 1928, leading to sun exposure minimization. However, epidemiological studies suggest that sun exposure correlates with increased life expectancy and reduced incidence of cardiovascular diseases and certain cancers such as colon and endometrial cancer. UVB exposure also influences liver metabolism, protects against hepatocellular lipotoxicity, and affects metabolic health. These effects are partly due to vitamin D synthesis, though some are independent of vitamin D. Moreover, phototherapy with UVB has immunomodulatory properties and is used to treat skin conditions such as vitiligo and psoriasis while also affecting the systemic immune system. Given UVB's broad physiological effects, there are gaps in understanding the mechanism behind most of these effects. We showed that daily low-level UVB exposure enhances food-seeking behavior in male mice but not in females due to increased ghrelin secretion from skin adipocytes. In females, estrogen inhibits adipocytes' p53 activity, blocking ghrelin elevation and demonstrating a sex-dependent response to UVB radiation. Additionally, UVB-induced p53 activation in epidermal keratinocytes activates the hypothalamus-pituitary-gonadal axis, inducing sexual behavior and ovarian pro-fertility. This paper outlines a protocol for studying local and systemic effects of low UVB radiation using a C57BL/6J mouse model. Key elements include precise calibration of UVB doses, housing conditions, and careful hair removal to ensure consistent exposure. Mice are subjected to a graded UVB exposure regime over several weeks, with monitoring for health and behavioral changes. Methods for validation of radiation efficiency through pigmentation measurements are also detailed. By emphasizing calibration of UVB doses, rigorous animal care, and methodological controls, this protocol will facilitate the study of the comprehensive effects of UVB exposure, contributing to a nuanced understanding of its therapeutic benefits and risks.
The frequencies of solar radiation that reach the earth's surface include ultraviolet (UV), UVA radiation (320-400 nm), and UVB radiation (280-320 nm). UVB is a mutation inducer. UV was recognized as a carcinogen in 19281, and from the mid-1900s, reducing sun exposure was recommended as a precautionary measure to avoid skin cancer2. Although UVB is clearly an environmental trigger for skin cancer, research in the past decade3 with recent studies from our group4,5,6 has shown that UVB has broad effects on physiological systems. A study of a cohort of women followed over 20 years revealed that life expectancy was higher by 2 years in women who did not avoid the sun compared to women who did7. Additional studies demonstrated that sun exposure was correlated with a decrease in cardiovascular disease and overall mortality8,9,10. Inverse correlations have also been reported between sunlight and colon cancer and endometrial cancer8. UVB exposure also induces liver metabolism11, protects against hepatocellular lipotoxicity and metabolic diseases, and has positive effects on endorphins and sexual-related behaviors3,6. These lines of evidence indicate the detrimental effects of avoidance of sun exposure on human health. The beneficial effects of sun exposure have been principally attributed to the induction of vitamin D production however, at least some of the health benefits of sunlight are independent of vitamin D levels4,6,12
Skin is the largest organ of the body, and it is the first line of defense against environmental stressors. The epidermal and dermal layers of skin are separated by a basal epidermal layer composed of undifferentiated, self-renewing keratinocytes and melanocytes10. Keratinocytes at increasing stages of terminal differentiation are found in the upper epidermal layer. The dermis includes fibroblasts and blood vessels, and the hypodermis mainly consists of adipocytes. The skin is a dermato-endocrine organ since multiple receptors of hormones, such as androgen receptor and corticotropin-releasing hormone receptor, are expressed in the skin, suggesting that hormones influence processes in the skin by paracrine and autocrine routes13,14,15. The skin is also a producer of hormones. With a few exceptions, however, hormone production in the skin and release into the blood has not been documented, nor are the triggers for expression known (review in16).
UVB has been shown to have therapeutic potential in skin diseases. Phototherapy, including psoralen-UVA and narrowband UVB therapy, is the principal treatment modality for generalized vitiligo17. Response to phototherapy occurred in 74% of patients at 6 months and 75% of patients at 12 months after initiation of treatment18. The mechanism of action of phototherapy in vitiligo is not well understood. Its therapeutic action involves a combination of effects on cell-cycle kinetics, alterations in cytokine expression, effects on melanocytes, and immunomodulation. Numerous studies have examined the effects of phototherapy on skin immunity19,20,21; however, the systemic effects are poorly understood, especially in the context of vitiligo. In contrast to psoriasis, where a study showed a decrease in proinflammatory cytokines and an increase in regulatory T cells after phototherapy treatment, in vitiligo, the number of regulatory T cells decreased with UV phototherapy21.
Although UVB has effects on the brain14,15, adrenal glands22, ovaries5,6, testicles6, liver11, and lymph nodes23, the mechanisms by which UVB modulates systemic systems are mostly not known. This research protocol describes a mouse model for studying the systemic and local (skin) effects of UVB exposure that will facilitate the study of the comprehensive effects of UVB exposure. The UVB mouse model is of broad interest in skin physiology, dermatology, and skin cancer, especially melanoma. The overall goal of this method is to provide a simple yet robust, effective protocol to develop the UVB mouse model for skin-related scientific research questions. The protocol describes how to overcome the challenges of skin erythema associated with hair removal and UVB exposure under physiological conditions and is effective in studying the local and systemic effects of UVB on skin.
Access restricted. Please log in or start a trial to view this content.
All the experimental procedures described were performed in accordance with the guidelines of the Tel Aviv University Institutional Animal Care and Use Committee (IACUC permit: 01-20-043).
1. Habituation of the mice for the experiment
2. Housing the mice
3. Shaving and hair removal
4. UVB exposure set-up
5. UVB exposure
6. UVB exposure analysis
NOTE: Mice were euthanized using CO2 asphyxiation according to AVMA Guidelines.
7. Animal care
Access restricted. Please log in or start a trial to view this content.
This method paper mentions the detailed step-by-step procedure of generating the UVB-exposure mouse model. Figure 1 clearly demonstrates the shaved area of the representative C57BL/6J mouse on the dorsal side prior to UVB exposure, demonstrating that 50%-60% of the dorsal area was shaved. The shaving protocol shows no sign of skin erythema, which is of utmost importance for dermatological studies. Figure 2 shows the set-up of the UVB exposure for the mice using ...
Access restricted. Please log in or start a trial to view this content.
UVB has long been recognized as an environmental risk factor for skin cancers; however, recent studies have illuminated a broader spectrum of UVB effects3. There is a need for studies that provide a deeper understanding of the systemic effects of UVB. The different doses used in basic research compared to clinical settings complicate our understanding of UVB effects, underscoring the importance of research that bridges these gaps.
The protocol for UVB exposure of C57BL/...
Access restricted. Please log in or start a trial to view this content.
The authors have no conflicts of interest.
C.L. acknowledges grant support from the European Research Council under the European Union's Horizon 2020 research and innovation programmer (grant agreement no. 726225), the I-CORE Gene Regulation in Complex Human Disease Center (no. 41/11), and the Israel Science Foundation (ISF; grant 129/13).
Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| Disinfectant | Amity international | Not applicable | |
| Exposure chamber | Made in house | Not applicable | |
| Hair removal cream | Veet | Not applicable | |
| Hair shaver | Heiniger | 707-303 120V US | |
| Isoflurane | Piramal Critical Care | Not applicable | |
| Isoflurane system | Kent Scientific | VetFlo-1210S | |
| PBS | Sigma Aldrich | TMS-012 | |
| Plexi-glass chamber | Made in house | Not applicable | |
| UVB lamp | Ultra-Violet Products | XX-Series - 15 Watt | |
| UVX radiometer | Ultra-Violet Products | 97-0015-02 |
Access restricted. Please log in or start a trial to view this content.